Perkins Coie Trust Company’s Ionis Pharmaceuticals IONS Stock Holding History

Perkins Coie Trust Company’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,000	Closed	-$47K	–	364
2020 Q1	$47K	Hold	1,000	–	–	0.02%	155
2019 Q4	$60K	Hold	1,000	–	–	0.02%	160
2019 Q3	$60K	Hold	1,000	–	–	0.03%	155
2019 Q2	$64K	Hold	1,000	–	–	0.03%	148
2019 Q1	$81K	Hold	1,000	–	–	0.04%	132
2018 Q4	$54K	Hold	1,000	–	–	0.03%	153
2018 Q3	$52K	Hold	1,000	–	–	0.02%	165
2018 Q2	$42K	Hold	1,000	–	–	0.02%	181
2018 Q1	$44K	Hold	1,000	–	–	0.02%	177
2017 Q4	$50K	Hold	1,000	–	–	0.03%	165
2017 Q3	$51K	Hold	1,000	–	–	0.03%	165
2017 Q2	$51K	Hold	1,000	–	–	0.03%	164
2017 Q1	$40K	Hold	1,000	–	–	0.02%	176
2016 Q4	$48K	Hold	1,000	–	–	0.03%	157
2016 Q3	$37K	Hold	1,000	–	–	0.02%	155
2016 Q2	$23K	Hold	1,000	–	–	0.02%	175
2016 Q1	$41K	Hold	1,000	–	–	0.03%	145
2015 Q4	$62K	Hold	1,000	–	–	0.05%	110
2015 Q3	$40K	Hold	1,000	–	–	0.03%	134
2015 Q2	$58K	Hold	1,000	–	–	0.04%	123
2015 Q1	$64K	Hold	1,000	–	–	0.05%	113
2014 Q4	$62K	Hold	1,000	–	–	0.05%	109
2014 Q3	$39K	Hold	1,000	–	–	0.03%	137
2014 Q2	$34K	Hold	1,000	–	–	0.03%	137
2014 Q1	$43K	Buy	+1,000	New	+$48.5K	0.04%	125

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Perkins Coie Trust Company's IONS Position: Q2 2020 in Review

Perkins Coie Trust Company sold out of Ionis Pharmaceuticals (IONS) in Q2 2020, closing a stake of 1,000 shares — an estimated $47K sold.

Perkins Coie Trust Company first reported a position in IONS in Q1 2014 and held it in 25 quarters. The position peaked at $81K in Q1 2019. 375 funds tracked by Wall St. Rank hold IONS as of Q2 2020.

Perkins Coie Trust Company reported no remaining Ionis Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Perkins Coie Trust Company sold 1,000 Ionis Pharmaceuticals shares in Q2 2020, an estimated $47K.
Perkins Coie Trust Company first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 25 quarters.
Perkins Coie Trust Company's Ionis Pharmaceuticals position peaked at $81K in Q1 2019.
375 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2020.

Based on Perkins Coie Trust Company's 13F filing for Q2 2020, filed 13 Jul 2020.